Studies have shown that MSC-Exo activated the extracellular signal-regulated protein kinase 1/2 (ERK1/2) signalling pathway or upregulated the expression of proliferating cell nuclear antigen (PCNA), accelerated tumour angiogenesis, and further promoted tumour development [112]. This evidence concerns the gene MAPK3 and neoplasm.